Abstract:Accumulating evidence indicates that abnormal deposition of amyloid‐β (Aβ) peptide in the brain is responsible for endothelial cell damage and consequently leads to blood–brain barrier (BBB) leakage. However, the mechanisms underlying BBB disruption are not well described. We employed an monolayer BBB model comprising bEnd.3 cell and found that BBB leakage was induced by treatment with Aβ1–42, and the levels of tight junction (TJ) scaffold proteins (ZO‐1, Claudin‐5, and Occludin) were decreased. Through comparisons of the effects of the different components of Aβ1–42, including monomer (Aβ1–42‐Mono), oligomer (Aβ1–42‐Oligo), and fibril (Aβ1–42‐Fibril), our data confirmed that Aβ1–42‐Oligo is likely to be the most important damage factor that results in TJ damage and BBB leakage in Alzheimer's disease. We found that the incubation of bEnd.3 cells with Aβ1–42 significantly up‐regulated the level of receptor for advanced glycation end‐products (RAGE). Co‐incubation of a polyclonal antibody to RAGE and Aβ1–42‐Oligo in bEnd.3 cells blocked RAGE suppression of Aβ1–42‐Oligo‐induced alterations in TJ scaffold proteins and reversed Aβ1–42‐Oligo‐induced up‐regulation of RAGE, matrix metalloproteinase (MMP)‐2, and MMP‐9. Furthermore, we found that these effects induced by Aβ1–42‐Oligo treatment were effectively suppressed by knockdown of RAGE using small interfering RNA (siRNA) transfection. We also found that GM 6001, a broad‐spectrum MMP inhibitor, partially reversed the Aβ1–42‐Oligo‐induced inhibitor effects in bEnd.3 cells. Thus, these results suggested that RAGE played an important role in Aβ‐induced BBB leakage and alterations of TJ scaffold proteins, through a mechanism that involved up‐regulation of MMP‐2 and MMP‐9. To reveal the role of RAGE in blood–brain barrier (BBB) disruption in Alzheimer's disease (AD), we employed an monolayer BBB model comprising bEnd.3 cell and found that BBB leakage was induced by treatment with amyloid‐β (Aβ), and the levels of tight junction (TJ) scaffold proteins including ZO‐1, Claudin‐5, and Occludin were decreased. Using receptor for advanced glycation end‐products (RAGE) neutralizing polyclonal antibody and siRNA, we confirmed that RAGE played an important role in Aβ‐induced BBB leakage and alterations of TJ scaffold proteins and in the up‐regulation of matrix metalloproteinase‐2 (MMP‐2) and matrix metalloproteinase‐9 (MMP‐9). NF‐κB, nuclear factor kappa‐light‐chain‐enhancer of activated B cells.

Amyloid-Beta-Induced Matrix Metalloproteinase-9 Secretion Is Associated With Retinal Pigment Epithelial Barrier Disruption

Aβ-induced Senescent Retinal Pigment Epithelial Cells Create a Proinflammatory Microenvironment in AMD.

Aβ1–42 oligomer‐induced leakage in an in vitro blood–brain barrier model is associated with up‐regulation of RAGE and metalloproteinases, and down‐regulation of tight junction scaffold proteins

Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration

Amyloid Beta Deposition Related Retinal Pigment Epithelium Cell Impairment And Subretinal Microglia Activation In Aged Appsweps1 Transgenic Mice

MMP9 Is Involved in Glycation End-Products Induced Increase of Retinal Vascular Permeability in Rats and the Therapeutic Effect of Minocycline

Endothelial Notch Signaling Regulates the Function of the Retinal Pigment Epithelial Barrier via EC Angiocrine Signaling

Tlr4 Inhibitor Attenuates Amyloid-Beta-Induced Angiogenic And Inflammatory Factors In Arpe-19 Cells: Implications For Age-Related Macular Degeneration

Role of Amyloid -Peptide in the Pathogenesis of Age-Related Macular Degeneration

Role of MMP-9 in the breakdown of barrier integrity of the corneal endothelium in response to TNF-α

Retinal protection by fungal product theissenolactone B in a sodium iodate-induced AMD model through targeting retinal pigment epithelial matrix metalloproteinase-9 and microglia activity

Aβ1–42 Oligomer Induces Alteration of Tight Junction Scaffold Proteins Via RAGE-mediated Autophagy in Bend.3 Cells

Subretinal Injection Of Amyloid-Beta Peptide Accelerates Rpe Cell Senescence And Retinal Degeneration

Distinct effects of inflammation on gliosis, osmohomeostasis, and vascular integrity during amyloid beta-induced retinal degeneration

Oligomeric Aβ1-42 Induces an AMD-Like Phenotype and Accumulates in Lysosomes to Impair RPE Function

Activated Microglia-Induced Neuroinflammatory Cytokines Lead to Photoreceptor Apoptosis in Age-Related Macular Degeneration-Like Mice Model

Effects of concentration of amyloid β (Aβ) on viability of cultured retinal pigment epithelial cells

SIRT1 Negatively Regulates Amyloid-Beta-induced Inflammation Via the NF-κB Pathway

Detecting Aβ Deposition and RPE Cell Senescence in the Retinas of SAMP8 Mice.

Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD

Key Role of Microglial Matrix Metalloproteinases in Choroidal Neovascularization